[Mechanisms and clinical research progress of mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease]. [PDF]
Wang N, Xu ZL, Liu DH.
europepmc +1 more source
免疫检查点抑制剂(ICIs)通过解除对免疫系统的抑制性调控机制,恢复并增强机体的抗肿瘤免疫应答,为肿瘤治疗带来里程碑式飞跃,彻底改变了多种恶性肿瘤的治疗模式,使部分患者的生存期显著延长。然而,临床实践中发现多数患者对ICIs治疗产生原发性耐药(初始治疗无应答)或获得性耐药(疾病得到控制后出现的耐药),极大地限制了其在临床上的广泛应用。ICIs耐药表型的产生可能源于不同的生物学机制,耐药机制复杂,涉及肿瘤细胞自身特性改变、肿瘤微环境重塑以及机体免疫系统状态等多个层面。深入探究ICIs耐药机制 ...
杨彩波, 符立梧
doaj
[<i>Shengmai San</i> improves osimertinib resistance of non-small cell lung cancer cells by regulating the lactate/Wnt/β-catenin/LDHA pathway]. [PDF]
Liang Z +6 more
europepmc +1 more source
[Overexpression of lncRNA SNHG12 promotes docetaxel resistance of prostate cancer cells by activating PI3K/AKT signaling <i>via</i> interacting with ELAVL1]. [PDF]
Zhao C +5 more
europepmc +1 more source
[Antitumor component-Ι in <i>Agkistrodon halys</i> venom inhibits proliferation and migration of cisplatin-resistant gastric cancer cells by downregulating RAI14]. [PDF]
Li Y +7 more
europepmc +1 more source
[Identification of SORD as A Key Gene Mediating Osimertinib Primary Resistance in EGFR-Mutant Lung Adenocarcinoma via Machine Learning and Methylomics]. [PDF]
Liang G +8 more
europepmc +1 more source
[Role and Mechanism of Hyaluronic Acid-modified Milk Exosomes in Reversing Pemetrexed Resistance in Lung Adenocarcinoma Cells]. [PDF]
Wu L, Lei J, Li H.
europepmc +1 more source
[Advances in Antibody-drug Conjugates for Non-small Cell Lung Cancer after Resistance to First-line Therapy]. [PDF]
Li H, Jing Y, Sun J, Xu J, Li Y.
europepmc +1 more source
[Establishment and Evaluation of a Nucleic Acid Amplification Test for Spectinomycin-Resistant <i>Neisseria gonorrhoeae</i>]. [PDF]
Yang G +5 more
europepmc +1 more source
[Carbapenemase Genes, Virulence Genes, and Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Derived From Bloodstream Infections]. [PDF]
Liao Q, Yuan Y, Zhang W, Deng J, Kang M.
europepmc +1 more source

